AJANTPHARM — Ajanta Pharma Share News
0.000.00%
- IN₹410.29bn
- IN₹405.00bn
- IN₹54.53bn
Brief: Ajanta Pharma says U.S. unit launches eletriptan hydrobromide tablets
Brief: India's Ajanta Pharma June-qtr profit falls
Brief: Ajanta Pharma says Ganga Exports sold 2.7 mln shares of co
Brief: Ajanta Pharma March-qtr consol profit rises
Brief: Ajanta Pharma's Dahej facility does not get form 483 after FDA inspection
Indian drugmakers face squeeze in U.S. healthcare market
Brief: Ajanta Pharma's Paithan facility been issued one procedural related 483 by USFDA
Brief: Ajanta Pharma Dec-qtr consol net profit rises
Brief: Ajanta Pharma says no import alert by US FDA on co's facility
Brief: Ajanta Pharma says haven't received any import alert by US FDA
Brief: Ajanta Pharma gets import alert from USFDA for its Aurangabad plant - FDA website
Brief: Ajanta Pharma gets USFDA nod for Duloxetine Hydrochloride delayed release capsules
Brief: Ajanta Pharma launches Voriconazole tablets in U.S.
Brief: Ajanta Pharma announces consolidation of promoter shareholding
Brief: Ajanta Pharma gets USFDA approval for Aripiprazole tablets
Brief: Ajanta Pharma gets US FDA approval for Omeprazole and Sodium Bicarbonate Powder
Brief: Ajanta Pharma gets US FDA approval for launch of Omeprazole and Sodium bicarbonate capsules in U.S.
Brief: Ajanta Pharma announces launch of memantine hydrochloride tablets in US
Brief: Ajanta Pharma gets USFDA approval for voriconazole tablets